Xylocard 100 100mg/5mL injection ampoule kit

देश: ऑस्ट्रेलिया

भाषा: अंग्रेज़ी

स्रोत: Department of Health (Therapeutic Goods Administration)

सक्रिय संघटक:

lidocaine hydrochloride, Quantity: 20 mg/mL

थमां उपलब्ध:

Aspen Pharmacare Australia Pty Ltd

फार्मास्यूटिकल फॉर्म:

Injection, solution

रचना:

Excipient Ingredients: sodium chloride; water for injections; sodium hydroxide

प्रशासन का मार्ग:

Intravenous

पैकेज में यूनिट:

5mL x 2, 5mL x 1, 5mL x 5

वर्ग:

Medicine Registered

प्रिस्क्रिप्शन प्रकार:

(S4) Prescription Only Medicine

चिकित्सीय संकेत:

INDICATIONS AS AT 15 AUGUST 1996: Cardiac arrhythmias. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

उत्पाद समीक्षा:

Visual Identification: Clear, colourless solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

प्राधिकरण का दर्जा:

Registered

प्राधिकरण की तारीख:

1991-08-13

सूचना पत्रक

XYLOCARD
®
1
XYLOCARD
®
_Lidocaine (Lignocaine) hydrochloride _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some of the
common questions people ask about
XYLOCARD. It does not contain all
the information that is known about
XYLOCARD.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor will have
weighed the risks of you taking
XYLOCARD against the benefits
they expect it will have for you.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT XYLOCARD IS
FOR
XYLOCARD is used to change an
abnormal beat in the heart back to
normal. It works by slowing nerve
impulses and reducing the
excitability of the heart.
XYLOCARD belongs to a group of
medicines known as antiarrhythmics.
Your doctor will have explained why
you are being treated with
XYLOCARD and told you what dose
you will be given.
FOLLOW ALL DIRECTIONS GIVEN TO YOU
BY YOUR DOCTOR CAREFULLY.
They may differ from the
information contained in this leaflet.
Your doctor may prescribe this
medicine for another use. Ask your
doctor if you want more information.
XYLOCARD is not addictive.
BEFORE YOU ARE GIVEN
XYLOCARD
_WHEN YOU MUST NOT USE IT _
IF YOU ARE PREGNANT OR
BREASTFEEDING DO NOT USE
XYLOCARD UNLESS YOUR DOCTOR
SAYS SO. ASK YOUR DOCTOR ABOUT THE
RISKS AND BENEFITS OF USING THIS
MEDICINE WHILE YOU ARE PREGNANT
OR BREASTFEEDING.
XYLOCARD has been widely used
during pregnancy and there have
been no reports of any ill effects on
the baby.
Your baby can take in very small
amounts of XYLOCARD from breast
milk if you are breastfeeding, but it is
unlikely that the amount available to
the baby will do any harm.
XYLOCARD WILL ONLY BE USED IF
THE SOLUTION IS CLEAR, THE PACKAGE IS
UNDAMAGED AND THE USE BY (EXPIRY)
DATE MARKED ON THE PACK HAS NOT
BEEN PASSED.
_BEFORE YOU ARE GIVEN IT _
YOU MUST TELL YOUR DOCTOR IF:
1.
YOU HAVE ANY ALLERGIES TO
•
ingredients listed at the end of
this leaflet
•
other antiarrhythmic medicines
•
local anaesthetics eg. b

उत्पाद विशेषताएं

1
AUSTRALIAN PRODUCT INFORMATION
XYLOCARD
LIDOCAINE (LIGNOCAINE) HYDROCHLORIDE
Antiarrhythmic agent
Solutions for injection and infusion
1
NAME OF THE MEDICINE
Lidocaine (lignocaine) hydrochloride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
The active ingredient in XYLOCARD

is lidocaine (lignocaine) hydrochloride.
Plain aqueous solutions are sterile, isotonic and contain lidocaine
(lignocaine) hydrochloride,
sodium hydroxide for pH adjustment and Water for Injections.
3
PHARMACEUTICAL FORM
All XYLOCARD solutions are clear and colourless.
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
Lidocaine
(lignocaine)
is
classed
as
a
membrane
stabilizing
agent;
local
anaesthetic
and
antiarrhythmic agent. It is extremely stable and plain solutions can
be sterilised by autoclaving,
repeated if necessary.
CARDIAC ARRHYTHMIAS
Treatment or prophylaxis of life-threatening ventricular arrhythmias,
including those associated
with
myocardial
infarction,
general
anaesthesia
in
patients
predisposed
to
ventricular
arrhythmias, digitalis intoxication, or following resuscitation from
cardiac arrest.
4.2
D
OSE AND METHOD OF ADMINISTRATION
XYLOCARD solutions contain no antimicrobial agent and should be used
in one patient on one
occasion only and any residue discarded.
CARDIAC ARRHYTHMIAS
Dosage is individual. The therapeutic serum concentration range is
5 - 20 micromol/L, 1.5 - 6.0 microgram/mL.
In the treatment of ventricular arrhythmias an intravenous injection
should be given first,
followed by an intravenous infusion.
ADULTS
PREINFUSION
2
INTRAVENOUS
To obtain therapeutic blood levels rapidly use lidocaine (lignocaine)
100 mg/5 mL in a dose of
lidocaine (lignocaine) 1 mg/kg bodyweight. Inject slowly IV, over a
period of 1 to 2 minutes.
The initial effect occurs in 2 to 4 minutes; maximum effect in about
10 minutes; duration 15 to 20
minutes. Infusion should be commenced within 10 minutes.
In the pre-hospital phase 50 - 100 mg doses may be administered at 10
to 20 minute intervals.
This dose corresponds to 1 mg/kg body weight pe